GlaxoSmithKline Q2 net dips 15% to Rs 98.29 cr
12/08/2014 17:41
Pharma major, GlaxoSmithKline Pharmaceuticals Ltd has reported 14.6 per cent decline in the standalone net profit at Rs 98.29 crore for the second-quarter ended June 30, 2014, despite higher sales. The Mumbai-based company had posted net profit at Rs 115.04 crore in the corresponding quarter last year, the company said in a filing to the Bombay Stock Exchange. Total Income has increased 2.6 per cent from Rs 682.220 crore for the quarter ended June 30, 2013 to Rs. 699.640 crore for the quarter ended June 30, 2014. The company follows January-December financial year. “The quarter continued to see the impact of the base effect of differential pricing cuts due to price control order, extending coverage to the National List of Essential Medicines (NLEM),” the company said. Meanwhile, shares of the company closed trading at Rs 2513.45 a piece, up 0.74 per cent from the previous close on BSE.
12/08/2014 17:41
Pharma major, GlaxoSmithKline Pharmaceuticals Ltd has reported 14.6 per cent decline in the standalone net profit at Rs 98.29 crore for the second-quarter ended June 30, 2014, despite higher sales. The Mumbai-based company had posted net profit at Rs 115.04 crore in the corresponding quarter last year, the company said in a filing to the Bombay Stock Exchange. Total Income has increased 2.6 per cent from Rs 682.220 crore for the quarter ended June 30, 2013 to Rs. 699.640 crore for the quarter ended June 30, 2014. The company follows January-December financial year. “The quarter continued to see the impact of the base effect of differential pricing cuts due to price control order, extending coverage to the National List of Essential Medicines (NLEM),” the company said. Meanwhile, shares of the company closed trading at Rs 2513.45 a piece, up 0.74 per cent from the previous close on BSE.
